Evidentia Learning helps hundreds of medical institutions all around the world train both specialists and frontline providers to recognize and respond to child abuse so they can meet their obligation as mandated reporters, reduce child abuse in their communities, and even save lives.Join for free at https://www.evidentialearning.com.

StartIN develops technology-enabled products in startups and enterprises with entrepreneurial ambitions. Key clients include:Wolters Kluwer, New York, NY 2010-2015Scientific, Technical and Medical Publisher.● Consultant, converted to employee. Managed the development of a key online clinical resource and the migration of an established platform to a new technical platform.Elsevier, St. Louis, MO 1996-2010Scientific, Technical and Medical Publisher.● Consultant to MD Consult, a fast-growing, and at the time, the first of its kind, online multi-publisher clinical resource.● As a consultant, promoted into multiple roles: IT Development, IT Management, Marketing and Product Development, Sales, and interim General Manager. Incyte Genomics, Palo Alto, CA 2000-2001● Managed technical teams in the development of software for Incyte Genomics’ Bioinformatics Workbench. The projects included the development of bioinformatics tools, plus the development of a full text search solution over the Medline database and Incyte’s custom gene annotations used in human genome sequencing and drug discovery.Marsh Technologies, St. Louis, MO 1999-2010● Developed software for the innovative Espresso On Demand Book printing system in use globally at more than 50 organizations such as Barnes and Noble, the MIT Press Bookstore, Harvard Bookstore, and the Library of Alexandria in Egypt.These projects reflect work performed under the ongoing business of StartIN, LLC and its predecessor, InterCorp, Inc.

Olin Business SchoolIT Audit and Control

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. Acquired by Roche.

Global online platform supporting medical research.

Multimedia Development; Kiosks

Retail; DistributionManaged multiple software teams responsible for developing and supporting multiple 24x7 distribution centers.

Business Computing Group; Skunkworks